Study guide

11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory

Utah MPJE Pharmacy Jurisprudence Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Utah Pharmacy Regulatory Framework, Facility Licensing & the PIC

1.1 DOPL, the Utah State Board of Pharmacy & the Sources of Utah Pharmacy Law 1.2 Federal vs. Utah Law: Following the Stricter Standard 1.3 Utah Pharmacy License Classes (A–E) & Facility Licensing 1.4 The Pharmacist-in-Charge (PIC): Duties, Self-Audits & Notifications 1.5 Facility Inspections, Ownership & Location Changes, Closing & Facility Discipline

2 Chapter 2: Pharmacist, Intern & Technician Licensure and Personnel

2.1 Pharmacist Licensure, the NAPLEX & Utah MPJE, and Licensure by Endorsement 2.2 License Renewal, Continuing Education & Reinstatement 2.3 Pharmacy Interns & Preceptors 2.4 Pharmacy Technicians, Technician Trainees & Supportive Personnel

3 Chapter 3: Unlawful & Unprofessional Conduct, Discipline, and Impairment

3.1 Unlawful Conduct, Criminal Penalties, Fines & the Disciplinary Process 3.2 Unprofessional Conduct, the APhA Code of Ethics & Utah's Conscience Law 3.3 Impairment, the Utah Professionals Health Program & Reinstatement

4 Chapter 4: Prescription Issuance, Prescriber Authority & Electronic Prescribing

4.1 Prescriber Scope of Authority in Utah 4.2 Required Prescription Elements, Oral & Faxed Orders, and Alterations 4.3 Mandatory Electronic Prescribing of Controlled Substances (EPCS) in Utah 4.4 Legitimate Medical Purpose, Corresponding Responsibility & Red Flags

5 Chapter 5: Patient Counseling, Prospective DUR, Confidentiality & Records

5.1 Patient Counseling: The Offer, Who May Counsel & Delivered Prescriptions 5.2 Prospective Drug Utilization Review & Patient Medication Profiles 5.3 Confidentiality, HIPAA & Protected Health Information 5.4 Pharmacy Records, Retention Periods & Facility Operating Standards

6 Chapter 6: Expanded Practice: Collaboration, Pharmacist Prescribing & Drug Administration

6.1 Collaborative Pharmacy Practice, Drug Therapy Management & Administration of Drugs 6.2 Self-Administered Hormonal Contraception: Standing Order & Pharmacist Prescribing 6.3 Pharmacist Prescribing Under Utah Code § 58-17b-627: Tobacco Cessation, HIV PrEP/PEP, Fluoride & Epinephrine 6.4 Vaccine Administration: DOPL's Protocol, Delegation, Emergencies & USIIS Reporting

7 Chapter 7: Opioid Overdose Prevention, Emergency Refills & Returned or Donated Drugs

7.1 Naloxone & Opioid-Safety Laws in Utah 7.2 Emergency Refills, Combined Refills & Insulin Continuity 7.3 Returned Drugs, Consumer Disposal & the Charitable Prescription Drug Recycling Program

8 Chapter 8: Controlled Substance Schedules, Registration & Security in Utah

8.1 Controlled Substance Schedules: Federal CSA & Utah-Specific Scheduling 8.2 DEA Registration & Facility Licensing 8.3 Controlled Substance Storage & Physical Security

9 Chapter 9: Dispensing Controlled Substances & the Utah Controlled Substance Database

9.1 Schedule II Prescriptions: 30-Day Window, One-Month Supply, Multiple Prescriptions & the 7-Day Acute Limit 9.2 Schedule II Partial Fills, Emergency Oral Orders & Methadone Emergency Orders 9.3 Schedule III–V Prescriptions: Refill Limits, the 80% Rule & Controlled Substance Transfers 9.4 The Utah Controlled Substance Database (CSD)

10 Chapter 10: Dispensing Standards: Labeling, Substitution, Refills, Packaging, Product Integrity & OTC Products

10.1 Prescription Labels: Utah Minimum Elements, Controlled Substance & Opioid Warnings, and Special Labels 10.2 Drug Product Selection: Generic Equivalents, Therapeutically Similar Drugs & Interchangeable Biologics 10.3 Legend-Drug Prescription Validity, Refills & Transfers 10.4 Poison Prevention Packaging Act (PPPA) & Special Packaging 10.5 Drug Product Conditions That Prohibit Dispensing: Adulterated, Misbranded, Outdated, Recalled & Suspect Products 10.6 Nonprescription Products: OTC Labeling & Packaging, Pseudoephedrine, Iodine, Schedule V & Other Restricted OTC Sales

11 Chapter 11: Acquisition, Inventory, Loss, Distribution & Delivery

11.1 Ordering Schedule II Substances: DEA Form 222 & CSOS 11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory 11.3 Theft, Significant Loss & Disposal of Controlled Substances 11.4 Drug Acquisition & Distribution, Office-Use Sales, and Delivering Prescriptions to Patients

12 Chapter 12: Compounding Standards, USP Chapters & Hazardous Drugs

12.1 Non-Sterile Compounding & USP <795> Standards 12.2 Sterile Compounding & USP <797> Standards 12.3 Hazardous Drug Handling & USP <800> Standards

13 Chapter 13: Institutional, Central Processing, Remote Dispensing, Specialty Outlets & Automation

13.1 Institutional Practice: Hospitals, Pharmaceutical Administration Facilities & Emergency Drug Kits 13.2 Centralized Prescription Processing, Telepharmacy & Remote Dispensing Pharmacies 13.3 Nuclear Pharmacies, Class E Outlets & Dispensing Medical Practitioners 13.4 Automated Pharmacy Systems, Quality Assurance & Pharmacy Audits

11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory

Key Takeaways Explain This Topic AI

Utah requires a controlled substance inventory within 12 months after each inventory date, which may be taken within four days of the specified date (R156-17b-605(4)).

A Utah inventory must include out-of-date drugs and drugs in automated pharmacy systems, and may be taken at the opening or close of business on the inventory date (R156-17b-605(2)).

Schedule I and II drugs require an exact count; Schedule III–V may be estimated unless the container holds more than 1,000 tablets or capsules, in which case an exact count is required.

The PIC must sign and date each initial, annual, change-of-ownership, and closing inventory within 72 hours or three working days, and inventories are kept five years, filed separately.

Every Utah pharmacy must keep a perpetual inventory of Schedule II controlled substances and reconcile it according to facility policy (R156-17b-605(6)).

Last updated: September 2026

11.2 Controlled Substance Inventories & Utah's Schedule II Perpetual Inventory

Blueprint item 4.2 includes "requirements for conducting controlled substance inventories." Utah's rule, R156-17b-605 , is stricter than federal law in frequency and adds a perpetual inventory requirement.

Federal baseline vs. Utah

Feature Federal (21 CFR 1304.11) Utah (R156-17b-605)

Initial inventory When first engaging in business On the opening day of business , including out-of-date drugs and drugs in automated systems. If there is no Schedule I or II stock, record that fact separately from the Schedule III–V record.

Periodic inventory At least every two years (biennial) Annual : within 12 months following the inventory date each year, and it may be taken within four days of the specified date

Change of ownership Inventory at transfer (21 CFR 1301.52) Inventory of legend drugs and controlled substances on the date of the qualifying ownership change. It is the seller's closing inventory and the buyer's initial inventory, and any Schedule I or II transfer uses DEA Form 222 .

Closing Per DEA discontinuance rules A closing inventory, attested in the surrender notice to DOPL (R156-17b-604(5))

Combining two pharmacies — A separate closing inventory for each pharmacy, then a combined opening inventory for the new pharmacy

  • Perpetual inventory Not required Required for Schedule II , reconciled according to facility policy
  • Retention 2 years 5 years , filed separately from other records
  • How to take the inventory (R156-17b-605(2))

Who: the PIC (or consulting pharmacist, RDPIC, or DMPIC) is responsible, but may delegate the counting.

When: at the opening or close of business on the inventory date. The person taking it and the PIC must state the time , and sign and date it with the date it was taken. The PIC's signature and date must be documented within 72 hours or three working days of an initial, annual, change-of-ownership, or closing inventory.

Form: written, typewritten, or printed. An inventory recorded by voice must be promptly transcribed .

Scope: every stock of controlled substances on hand on the inventory date, including out-of-date drugs and drugs in automated pharmacy systems .

Separation: list Schedule I and II separately from Schedules III–V , and file inventories separately from other records.

Perpetual reconciliation: if a perpetual inventory is kept for any drug being inventoried, reconcile it on the inventory date .

Counting rules

  • Schedule Counting method
  • I and II Exact count or measure

III, IV, V Estimated count or measure permitted, but if the container holds more than 1,000 tablets or capsules , make an exact count

The federal rule is similar: exact counts for Schedule I and II, and estimated counts for opened Schedule III–V containers unless the container originally held more than 1,000 units. Federal inventories also record the registrant's name, address, and DEA number, the date and whether the count was at opening or close, and for each item the name, strength, dosage form, units per container, and number of containers.

The Schedule II perpetual inventory (R156-17b-605(6))

"A pharmacy shall maintain a perpetual inventory of Schedule II controlled substances that shall be reconciled according to facility policy." Utah requires the perpetual inventory for every pharmacy, not only hospitals or compounding pharmacies, and leaves the reconciliation schedule to the pharmacy's written policy. Good practice is to:

record each receipt (with the invoice or Form 222 reference), each dispensing (prescription number and quantity), transfer, return, and destruction as it occurs;

reconcile the book balance against a physical count on a set schedule (for example, weekly or monthly) and at each annual inventory; and

investigate discrepancies promptly. Unexplained shortages may be a theft or significant loss requiring DEA and DOPL reporting (Section 11.3).

Remote dispensing pharmacies must document monthly inspections that include maintenance of a perpetual inventory of Schedule II drugs and reconciliation of any controlled substances (R156-17b-614g(10)).

When a drug becomes controlled

Federal law requires an inventory of a newly scheduled substance on the effective date of the scheduling (21 CFR 1304.11(d)). Utah's 2024 gabapentin scheduling is the local example. Gabapentin became Utah Schedule V on May 1, 2024 , and DOPL directed pharmacies to take an initial gabapentin inventory on or after May 1 but before May 31, 2024 , and to include gabapentin in each annual controlled-substance inventory from then on.

Related records

Receipts: a pharmacist or other responsible person must verify that controlled substances on suppliers' invoices were actually received, by initialing and dating the invoice with the actual receipt date. Keep credit memos for controlled substances (R156-17b-614a(11)–(12)).

DOPL access: inventory copies must be made available to DOPL on request (R156-17b-614a(13)). Failing to account for shortages, or refusing to make inventory available for inspection, is unprofessional conduct (R156-37-502(5), (7)).

Scenario

A pharmacy's last annual inventory was taken June 10, 2025 at close of business. The next must be taken within 12 months, by about June 10, 2026 (the rule allows four days either way), at opening or close of business. It includes expired stock and automated-cabinet stock, and the PIC signs within 72 hours or three working days. Schedule II items are counted exactly. A 1,000-count bottle of acetaminophen/codeine with about 600 tablets left may be estimated. A 5,000-count bottle of a Schedule IV drug must be counted exactly.